Breaking News
Dead Simple Apocalypse Power: Build It in an Hour
ALEX JONES RETURNS TO FORMER INFOWARS STUDIO
The Fauci Diaries: Three Volumes, Fully Indexed
Gritt and MasTec partner to bring physical AI to solar construction sites
Top Tech News
Musk's Starlink Is Building An Orbital Bypass As Undersea Cable Sabotage Threats Mount
A robot just built a structure in space for the first time
The Greatest Theft in Human History
3D-Printed Tungsten Survives 74 Fusion Plasma Discharges, Advancing the Engineering...
Dude turns a $23 used smartphone into the 4G brain of an RC aircraft.
China's World-Beating Supercar Just Hit 312 MPH
Pentagon Delivers 25,000+ Drones And Counter-Drone Systems To CENTCOM In A "Massive Surge"
Prism puts an eye-controlled Linux computer on your face
Remember Yesterday: AI For Today and Tomorrow
Robot Mowers Invade America's Golf Courses, Putting Groundskeepers On Notice
Samumed worth $12 billion is working on tissue regeneration to combat alzheimers and more
They have a biotechnology platform based on small molecule-based Wnt pathway modulation, they develop therapeutics to address a range of degenerative diseases, regenerative medicine and oncology.
One of the primary signaling pathways that regulate the self-renewal and differentiation of adult stem cells is the Wnt pathway, which plays a crucial role in tissue health, ranging from formation to replenishment and from repair to regeneration of various tissues.
Samumed's small-molecule drug platform is harnessing the innate restorative power of the Wnt pathway to reverse the course of severe and prevalent diseases.